Theralase Technologies Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Theralase Technologies Inc. (TLTFF) is 55.43M

According to Theralase Technologies Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 55.43M. This represents a change of -4.24% compared to the average of 57.88M of the last 4 quarters.

Theralase Technologies Inc. (TLTFF) Historical Enterprise Value (quarterly & annually)

How has TLTFF Enterprise Value performed in the past?

The mean historical Enterprise Value of Theralase Technologies Inc. over the last ten years is 44.98M. The current 55.43M Enterprise Value has changed 23.24% with respect to the historical average. Over the past ten years (40 quarters), TLTFF's Enterprise Value was at its highest in in the March 2022 quarter at 91.44M. The Enterprise Value was at its lowest in in the September 2020 quarter at 19.91M.

Theralase Technologies Inc. (TLTFF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Theralase Technologies Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Theralase Technologies Inc. (TLTFF) Average Enterprise Value

How has TLTFF Enterprise Value performed in the past?

The current Enterprise Value of Theralase Technologies Inc. (TLTFF) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Theralase Technologies Inc. (TLTFF) Enterprise Value vs. Peers

How is TLTFF’s Enterprise Value compared to its peers?

Theralase Technologies Inc.’s Enterprise Value is greater than Defence Therapeutics Inc. (21.44M), less than Helix BioPharma Corp. (81.26M), less than BetterLife Pharma Inc. (149.86M), greater than BriaCell Therapeutics Corp. (16.94M), less than Resverlogix Corp. (96.00M), less than Arch Biopartners Inc. (56.39M), greater than Vaxil Bio Ltd. (-65598.00), less than Rakovina Therapeutics Inc (0), less than Onco-Innovations Limited (0), less than Eupraxia Pharmaceuticals Inc. (392.17M),

Build a custom stock screener for Theralase Technologies Inc. (TLTFF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theralase Technologies Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theralase Technologies Inc. (TLTFF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theralase Technologies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.